Archived news features

  • Researchers from the LSTM-based Cochrane Infectious Disease Group (CIDG) explored whether community administration of ivermectin influences malaria transmission.Malaria still kills millions. Researchers are excited by a new intervention: giving people a drug which kills mosquitoes that bite them. Incredibly, this is a reality, as the drug...
    June 30 2021
  • During June 2021, the CIDG published two Cochrane protocols, two new Cochrane reviews, and one Cochrane review update in Issue 6, 2021 of the Cochrane Database of Systematic Reviews.ProtocolsLeeflang MMG, Bell K, Deeks JJ, Dinnes J, Doust J, Korevaar DA, Lord SJ, Spijker R. Electronic and animal noses...
    June 30 2021
  • Researchers from LSTM confirm that in areas with high pyrethroid resistance in mosquitoes, fewer people were infected with malaria parasites when piperonyl butoxide (PBO) + pyrethroid-treated bed nets were used. The updated Cochrane Review shows these benefits were sustained over two years.Bed nets treated with pyrethroid insecticides are an...
    May 24 2021
  • In this ‘Meet the CIDG staff’ feature we chat with Melissa Taylor, who joined the CIDG editorial base as a Research Assistant in November 2019. Melissa is authoring several qualitative evidence synthesis titles with the CIDG, including ‘Mass drug administration for filariasis: community views and programme design influences’ and ‘Community views...
    April 13 2021
  • LSTM’s Centre for Evidence Synthesis in Global Health has led developments in systematic reviews in tropical medicine and international health. In the 1990s, staff contributed to setting up Cochrane, and established the Cochrane Infectious Diseases Group (CIDG). This is now recognised as one of Cochrane’s premier groups, with over 150...
    April 8 2021
  • One new Cochrane protocol, one new Cochrane review, and two updated COVID-19 Cochrane reviews are in Issue 3, 2021 of the Cochrane Database of Systematic Reviews. New ProtocolMedley  N, Taylor  M, van Wyk  SS, Oliver  S. Community views on active case finding for tuberculosis in low‐ and...
    April 1 2021
  • A new Cochrane editorial examines the 2020 story of chloroquine or hydroxychloroquine for treating COVID-19. Read the full Cochrane editorial here. During the past 12 months chloroquine and hydroxychloroquine have been touted as miracle cures for COVID‐19 and introduced into COVID‐19 treatment protocols in Asia, Africa, and North and...
    March 26 2021
  • How accurate are rapid tests for diagnosing COVID‐19? What are rapid point‐of‐care tests for COVID‐19?Rapid point‐of‐care tests aim to confirm or rule out COVID‐19 infection in people with or without COVID‐19 symptoms. They:‐ are portable, so they can be used wherever the patient is (at the point of care);‐ are easy to perform, with a minimum...
    March 24 2021
  • The Cochrane Library releases an updated Special Collection on diagnosing tuberculosisWorld Tuberculosis Day is marked annually on 24 March, and commemorates the date in 1882 when Dr Robert Koch announced his discovery of Mycobacterium tuberculosis, the bacillus that causes tuberculosis.This Special Collection, curated by Cochrane...
    March 23 2021
  • How accurate are sputum Xpert tests for screening for active pulmonary tuberculosis and rifampicin resistance in adults whether or not they have tuberculosis symptoms?Why is using Xpert tests to screen for pulmonary tuberculosis important?Tuberculosis is the leading cause of infectious disease‐related death and one of the top 10 causes of death...
    March 23 2021

Pages

Subscribe to Our news